Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Icenticaftor in Healthy Volunteers and Cystic Fibrosis Patients
NCT02190604Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jul 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of Icenticaftor in cystic fibrosis (CF), sponsored by Novartis. Started Jul 2012; status: terminated.
02
Drugs
Icenticaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02190604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02190604.